Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
12.64
-0.06 (-0.47%)
At close: Jun 12, 2026, 4:00 PM EDT
12.71
+0.07 (0.55%)
After-hours: Jun 12, 2026, 7:21 PM EDT
Q32 Bio Revenue
Q32 Bio had revenue of $53.74M in the twelve months ending March 31, 2026. In the year 2025, Q32 Bio had annual revenue of $53.74M.
Revenue (ttm)
$53.74M
Revenue Growth
n/a
P/S Ratio
3.99
Revenue / Employee
$2,442,591
Employees
22
Market Cap
214.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.74M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | -6.65M | -9.86M | - |
| Dec 31, 2022 | 3.21M | -30.76M | -90.56% |
| Dec 31, 2021 | 33.97M | 31.27M | 1,157.25% |
| Dec 31, 2020 | 2.70M | 1.04M | 62.18% |
| Dec 31, 2019 | 1.67M | -3.66M | -68.70% |
| Dec 31, 2018 | 5.32M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 151.12M |
| Codexis | 78.09M |
| Coherus Oncology | 46.88M |
| Atrium Therapeutics | 36.68M |
| Voyager Therapeutics | 36.49M |
| LENZ Therapeutics | 20.99M |
QTTB News
- 18 hours ago - Q32 Bio Transcript: AGM 2026 - Transcripts
- 15 days ago - 3 Penny Stocks to Watch Now, 5/28/26 - TipRanks
- 16 days ago - Q32 Bio Inc trading halted, volatility trading pause - TheFly
- 16 days ago - Q32 Bio Inc trading resumes - TheFly
- 16 days ago - Q32 Bio announces $55M private placement - TheFly
- 16 days ago - Q32 Bio Announces $55 Million Private Placement Financing - PRNewsWire
- 21 days ago - Q32 Bio initiated with an Outperform at Mizuho - TheFly
- 25 days ago - Q32 Bio initiated with an Overweight at Cantor Fitzgerald - TheFly